Product Information

METHYLPHENIDATE ER 18 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.5758 per EA under NDC 31722095201. Its NADAC has been published 358 times since Oct 16, 2019.

FDA first approved this application on Sep 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER 18 MG TAB

Methylphenidate Hydrochloride
$0.5758per EA
DEA Schedule CII

Strength

18 mg/1

NDC

31722095201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211009

FDA Approved

9/3/2019

TE Code

AB

On Market Since

9/3/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 18 MG TAB has been published 358 times since Oct 16, 2019, and over the history we have for it it has declined 88.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5758 per EA
All-time high$5.1005 (Oct 16, 2019)
All-time low$0.5230 (Jul 20, 2022)
52-week high$0.7051
52-week low$0.5758
Median price$0.7286
Average price$1.1511
Largest weekly change-50.2% (Jul 22, 2020)
Weeks tracked358
Tracking sinceOct 16, 2019

Price History

1W

-3.8%

1M

-3.8%

3M

-6.8%

6M

-8.8%

1Y

-18.3%

3Y

-41.1%

5Y

-43.9%

All

-88.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 18 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 18 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.5758 per EA (NDC 31722095201), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE ER 18 MG TAB changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 18 MG TAB has declined 88.7%. It has been tracked across 358 weekly CMS publications since Oct 16, 2019.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 18 MG TAB?

Since Oct 16, 2019, the NADAC for METHYLPHENIDATE ER 18 MG TAB has ranged from a low of $0.5230 (Jul 20, 2022) to a high of $5.1005 (Oct 16, 2019), with a median of $0.7286 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 18 MG TAB?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER 18 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER 18 MG TAB?

METHYLPHENIDATE ER 18 MG TAB (NDC 31722095201) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.